Marlies S Wijsenbeek

Sep 12, 2023 | jamanetwork.com | Toby Maher |Paul Ford |Galapagos NV |Marlies S Wijsenbeek

Ziritaxestat and Lung Function in Idiopathic Pulmonary Fibrosis—Reply Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis Toby M. Maher, MD, PhD; Paul Ford, MD, PhD; Kevin K. Brown, MD; Ulrich Costabel, MD, PhD; Vincent Cottin, MD, PhD; Sonye K. Danoff, MD, PhD; Irene Groenveld, MSc; Eric Helmer, PharmD; R. Gisli Jenkins, MD, PhD; Julie Milner, PhD; Geert Molenberghs, PhD; Bjorn Penninckx, MD; Matthew J.

Jun 1, 2023 | books.ersjournals.com | Peter M.A. Calverley |Thomas Wagner |Marc Humbert |Marlies S Wijsenbeek

Diagnosing rare diseases can be challenging, and treating these conditions is complex because of their often quite specific needs and treatment options. To address this, the European Respiratory Society (ERS) has published Rare Diseases of the Respiratory System.